
Taeyoon Kim
Examiner (ID: 4325, Phone: (571)272-9041 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1631, 1632 |
| Total Applications | 1176 |
| Issued Applications | 467 |
| Pending Applications | 170 |
| Abandoned Applications | 584 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5742783
[patent_doc_number] => 20060088508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Method for obtaining characterized muscle-derived cell populations and uses'
[patent_app_type] => utility
[patent_app_number] => 11/207795
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16530
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088508.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207795 | Method for obtaining characterized muscle-derived cell populations and uses | Aug 21, 2005 | Abandoned |
Array
(
[id] => 5590540
[patent_doc_number] => 20060039991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Biological tissue regenerative agent and method for preparing and using same'
[patent_app_type] => utility
[patent_app_number] => 11/208231
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11159
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208231
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208231 | Biological tissue regenerative agent and method for preparing and using same | Aug 18, 2005 | Abandoned |
Array
(
[id] => 14637095
[patent_doc_number] => 10363275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Isolation, cultivation and uses of stem/progenitor cells
[patent_app_type] => utility
[patent_app_number] => 11/205248
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 71
[patent_no_of_words] => 16114
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11205248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205248 | Isolation, cultivation and uses of stem/progenitor cells | Aug 14, 2005 | Issued |
Array
(
[id] => 8200508
[patent_doc_number] => 08187878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/573662
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 15307
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/187/08187878.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573662 | Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors | Aug 14, 2005 | Issued |
Array
(
[id] => 5826891
[patent_doc_number] => 20060062770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Organogenesis from dissociated cells'
[patent_app_type] => utility
[patent_app_number] => 11/203804
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7878
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203804 | Organogenesis from dissociated cells | Aug 14, 2005 | Abandoned |
Array
(
[id] => 5050796
[patent_doc_number] => 20070031341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Methods of delivering therapeutics to the brain'
[patent_app_type] => utility
[patent_app_number] => 11/200438
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8879
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11200438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/200438 | Methods of delivering therapeutics to the brain | Aug 7, 2005 | Abandoned |
Array
(
[id] => 504170
[patent_doc_number] => 07202063
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-04-10
[patent_title] => 'Processes for the production of rhamnolipids'
[patent_app_type] => utility
[patent_app_number] => 11/195956
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6184
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11195956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/195956 | Processes for the production of rhamnolipids | Aug 2, 2005 | Issued |
Array
(
[id] => 4675600
[patent_doc_number] => 20080213229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Fibrin Contained Semi-Solid Osteoblast Composition for Curing Bone Fracture and Method for Producing the Same'
[patent_app_type] => utility
[patent_app_number] => 11/885943
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3528
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213229.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885943 | Fibrin Contained Semi-Solid Osteoblast Composition for Curing Bone Fracture and Method for Producing the Same | Aug 2, 2005 | Abandoned |
Array
(
[id] => 5206061
[patent_doc_number] => 20070027543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Use of adipose tissue-derived stromal cells in spinal fusion'
[patent_app_type] => utility
[patent_app_number] => 11/194270
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18000
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11194270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/194270 | Use of adipose tissue-derived stromal cells in spinal fusion | Jul 31, 2005 | Abandoned |
Array
(
[id] => 5912328
[patent_doc_number] => 20060127390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Enzymatic inactivation of transmissible spongiform encephalopathy agents and dectection there of'
[patent_app_type] => utility
[patent_app_number] => 11/191847
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5606
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191847 | Enzymatic inactivation of transmissible spongiform encephalopathy agents and dectection there of | Jul 28, 2005 | Abandoned |
Array
(
[id] => 4758858
[patent_doc_number] => 20080311084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Mapc Engraftment in the Hematopoietic System'
[patent_app_type] => utility
[patent_app_number] => 11/919899
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21511
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311084.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919899 | Mapc Engraftment in the Hematopoietic System | Jul 28, 2005 | Abandoned |
Array
(
[id] => 5446031
[patent_doc_number] => 20090047257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Novel cell populations and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/658065
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14554
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658065 | Novel cell populations and uses thereof | Jul 19, 2005 | Abandoned |
Array
(
[id] => 5601790
[patent_doc_number] => 20060292135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl'
[patent_app_type] => utility
[patent_app_number] => 11/186018
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 39010
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 101
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186018 | Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl | Jul 17, 2005 | Abandoned |
Array
(
[id] => 4807410
[patent_doc_number] => 20080170988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Method of Preparing Nanoparticles of Alginate-Galactosyl-Polylsine'
[patent_app_type] => utility
[patent_app_number] => 11/663120
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 983
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20080170988.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663120 | Method of Preparing Nanoparticles of Alginate-Galactosyl-Polylsine | Jul 17, 2005 | Abandoned |
Array
(
[id] => 4710575
[patent_doc_number] => 20080299101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Cancer Treatment Resistance and Agents Modulating Such Resistance'
[patent_app_type] => utility
[patent_app_number] => 11/571798
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 4256
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571798 | Cancer Treatment Resistance and Agents Modulating Such Resistance | Jul 7, 2005 | Abandoned |
Array
(
[id] => 6391478
[patent_doc_number] => 20100303765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Scaffoldless Constructs for Tissue Engineering of Articular Cartilage'
[patent_app_type] => utility
[patent_app_number] => 11/571790
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3971
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571790 | Scaffoldless Constructs for Tissue Engineering of Articular Cartilage | Jul 7, 2005 | Abandoned |
Array
(
[id] => 4644081
[patent_doc_number] => 08021684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Haemostatic composition comprising hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 10/562831
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13597
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/021/08021684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562831 | Haemostatic composition comprising hyaluronic acid | Jul 6, 2005 | Issued |
Array
(
[id] => 5069068
[patent_doc_number] => 20070190169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Dendritic cells, pharmaceutical composition comprising said dendritic cells, therapeutic method and yo t-cell culture method utilizing said dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 11/631660
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4705
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631660
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631660 | Dendritic cells pulsed with a bisphosphonate | Jul 6, 2005 | Issued |
Array
(
[id] => 10089001
[patent_doc_number] => 09125804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose'
[patent_app_type] => utility
[patent_app_number] => 11/632156
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4887
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11632156
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632156 | Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose | Jul 5, 2005 | Issued |
Array
(
[id] => 6576220
[patent_doc_number] => 20100047220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Substances'
[patent_app_type] => utility
[patent_app_number] => 11/597252
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11147
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597252 | Cells expressing a modified T cell receptor | Jun 28, 2005 | Issued |